欢迎来到天天文库
浏览记录
ID:55314713
大小:269.13 KB
页数:3页
时间:2020-05-14
《复发或转移口腔鳞状细胞癌的时辰化疗.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、2376重庆医学2015年6月第44卷第17期论著·临床研究doi:10.3969/j.issn.1671—8348.2015.17.025复发或转移口腔鳞状细胞癌的时辰化疗程珏,陈丹,杨凯,唐洪(重庆医科大学附属第一医院口腔颌面外科400016)[摘要]目的分析比较用紫杉醇、卡铂和5一氟尿嘧啶(5-Fu)联合方案对复发和(或)转移口腔鳞状细胞癌(OSCC)行时辰化疗和传统化疗的疗效扣不良反应。方法回顾分析49例用紫杉醇、卡铂联合5一Fu进行姑息化疗的复发和(或)转移的OSCC患者。因给药时间不同,分为时辰化疗组(28例)和传统化疗组(21例)。比较两组患者的有效率、中位总
2、体生存时间、中位无进展生存时间和不良反应发生率。结果时辰化疗组的有效率和中位总体生存时间显著高于传统化疗组(有效率分别为71.43%、42.86,P3、39.85[文献标识码]A[文章编号]1671—8348(2015)17—2376—03ThechronochemotherapyofpatientswithrecurrentormetastaticoralsquamouscellcarcinomaChengJue,ChenDan,YangKai,TangHong(DepartmentofOrlaandMaxillofacialSurgery,theFirstAffiliatedHosptitalofchongqingMedicalUniversity,Chongqing40016,China)[Abstract]Obje4、ctiveToevaluatetheeffectandtoxicitiesofehronochemotherapywithpaelitaxel,carboplatinand5-fluorou—racilinpatientswithrecurrentand/ormetastaticoralsquamouscel1carcinoma(OSCC).MethodsRetrospectiveanalysesweremade0n49patientswithrecurrentand/ormetastaticOSCCwhounderwentpalliativetreatmentswithp5、aclitaxel,carboplatinand5-flu—orouracil.Thepatientsweredividedinto2groups,achronochemotherapygroup(28patients)andaconventionalchemotherapygroup(21patients),accordingtotheiradministrationtimes.Theeffectiverate,medianoverallsurvival(OS),medianprogression—freesurvival(PFS),andtheincidenceofad6、verseeventswerecomparedbetweenthetwogroups.ResultsTheeffectiverateandpatientsmedianOSweresignificantlyhigherandlongerinthechronochemotherapygroupthanthoseintheconventionalchemotherapygroup(effectiverate71.43vs.42.86,respectively,P<0.05;andmedianOS15.3months73s.10.6months,respectively,P<0.07、5).Theglobalincidenceofadverseeventsinthechronomodulatedchemotherapygroupwassignificantlylowerthanthatintheconventionalchemotherapygroup(46.43vs.76.19,P
3、39.85[文献标识码]A[文章编号]1671—8348(2015)17—2376—03ThechronochemotherapyofpatientswithrecurrentormetastaticoralsquamouscellcarcinomaChengJue,ChenDan,YangKai,TangHong(DepartmentofOrlaandMaxillofacialSurgery,theFirstAffiliatedHosptitalofchongqingMedicalUniversity,Chongqing40016,China)[Abstract]Obje
4、ctiveToevaluatetheeffectandtoxicitiesofehronochemotherapywithpaelitaxel,carboplatinand5-fluorou—racilinpatientswithrecurrentand/ormetastaticoralsquamouscel1carcinoma(OSCC).MethodsRetrospectiveanalysesweremade0n49patientswithrecurrentand/ormetastaticOSCCwhounderwentpalliativetreatmentswithp
5、aclitaxel,carboplatinand5-flu—orouracil.Thepatientsweredividedinto2groups,achronochemotherapygroup(28patients)andaconventionalchemotherapygroup(21patients),accordingtotheiradministrationtimes.Theeffectiverate,medianoverallsurvival(OS),medianprogression—freesurvival(PFS),andtheincidenceofad
6、verseeventswerecomparedbetweenthetwogroups.ResultsTheeffectiverateandpatientsmedianOSweresignificantlyhigherandlongerinthechronochemotherapygroupthanthoseintheconventionalchemotherapygroup(effectiverate71.43vs.42.86,respectively,P<0.05;andmedianOS15.3months73s.10.6months,respectively,P<0.0
7、5).Theglobalincidenceofadverseeventsinthechronomodulatedchemotherapygroupwassignificantlylowerthanthatintheconventionalchemotherapygroup(46.43vs.76.19,P
此文档下载收益归作者所有